Abstract
Selaginellin derivatives 1-3 isolated from Selaginella tamariscina were evaluated for their inhibition of soluble epoxide hydrolase (sEH) to demonstrate their potential for the treatment of cardiovascular disease. All selaginellin derivatives (1-3) inhibited sEH enzymatic activity and PHOME hydrolysis, in a dose-dependent manner, with IC50 values of 3.1 ± 0.1, 8.2 ± 2.2, and 4.2 ± 0.2 μM, respectively. We further determined that the derivatives function as non-competitive inhibitors. Moreover, the predicted that binding sites and interaction between 1-3 and sEH were solved by docking simulations. According to quantitative analysis, 1-3 were confirmed to have high content in the roots of S. tamariscina; among them, selaginellin 3 exhibited the highest content of 189.3 ± 0.0 μg/g.
Original language | English |
---|---|
Pages (from-to) | 21405-21414 |
Number of pages | 10 |
Journal | Molecules |
Volume | 20 |
Issue number | 12 |
DOIs | |
State | Published - 2 Dec 2015 |
Keywords
- Non-competitive inhibition
- Selaginella tamariscina
- Selaginellaceae
- Selaginellin
- Soluble epoxide hydrolase